New gout drug dotinurad shows promise in early trial
NCT ID NCT06056570
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested a new drug called dotinurad in 20 U.S. adults with gout and high uric acid. Researchers looked at how the drug works in the body, both alone and when taken with the standard gout medicine allopurinol. The goal was to understand dosing and potential drug interactions, not to prove long-term benefits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dotinurad
What this could lead to
If successful, dotinurad could offer a new option to lower uric acid in people with gout, possibly working well with allopurinol.
What could go wrong
This is a small, early-phase study (20 people) focused on drug levels and interactions, not on long-term safety or effectiveness. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERURICEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research of West Florida
Clearwater, Florida, 33765, United States
-
Endeavor Clinical Trials
San Antonio, Texas, 78240, United States
-
Panax Clinical Research
Miami Lakes, Florida, 33014, United States
-
Southwest Rheumatology Research
Mesquite, Texas, 75150, United States